ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,584.54
      -0.88%
      US Tech 100
      19,688.80
      -2.14%
      Dow Jones
      39,753.75
      0.08%
      Brent Oil
      85.11
      0.07%
      Bitcoin
      57,224.63
      -0.92%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Precipio Inc (PRPO)

      7. Precipio Inc (PRPO) News

      PRPO

      Precipio (PRPO)

      Precipio Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:PRPO
      DateTimeSourceHeadlineSymbolCompany
      12:21PMiHub NewswireFeaturedCannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing
      05/04/20231:00PMGlobeNewswire Inc.Precipio Adds Substantial Pathology Customer to its Diagnostic Services DivisionNASDAQ:PRPOPrecipio Inc
      05/04/202310:00AMGlobeNewswire Inc.Precipio Signs Another HemeScreen™ CustomerNASDAQ:PRPOPrecipio Inc
      04/28/20236:20AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:PRPOPrecipio Inc
      04/27/20235:00PMGlobeNewswire Inc.Precipio Granted 180-day Extension From NASDAQ To Regain ComplianceNASDAQ:PRPOPrecipio Inc
      04/25/20234:26PMEdgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)NASDAQ:PRPOPrecipio Inc
      04/25/20234:13PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:PRPOPrecipio Inc
      04/19/202311:00AMGlobeNewswire Inc.Precipio Unaudited Q1-2023 Product Revenues Exceed The Two Prior Quarters (Q3+Q4 of 2022) CombinedNASDAQ:PRPOPrecipio Inc
      04/17/20236:01AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PRPOPrecipio Inc
      04/14/20234:44PMEdgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:PRPOPrecipio Inc
      04/14/20234:41PMEdgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:PRPOPrecipio Inc
      03/30/20235:00PMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:PRPOPrecipio Inc
      03/29/20234:01PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PRPOPrecipio Inc
      03/28/20235:00PMGlobeNewswire Inc.Precipio Announces 2022 Fourth Quarter and Year-End Shareholder Update CallNASDAQ:PRPOPrecipio Inc
      03/21/202310:30AMGlobeNewswire Inc.Precipio Ships First IV-Cell® Order to Major US Healthcare SystemNASDAQ:PRPOPrecipio Inc
      03/07/202312:49PMGlobeNewswire Inc.CORRECTION -- Precipio continues to sign up and onboard HemeScreen™ customersNASDAQ:PRPOPrecipio Inc
      03/07/202312:00PMGlobeNewswire Inc.Precipio continues to sign up and onboard HemeScreen™ customersNASDAQ:PRPOPrecipio Inc
      02/14/202311:44AMGlobeNewswire Inc.ThermoFisher Salesforce Votes Precipio’s HemeScreen® as “Best New Product”NASDAQ:PRPOPrecipio Inc
      01/11/202310:00AMGlobeNewswire Inc.Precipio Signs Another Major HemeScreen™ CustomerNASDAQ:PRPOPrecipio Inc
      01/10/20234:48PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PRPOPrecipio Inc
      01/10/20234:48PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PRPOPrecipio Inc
      01/10/20234:46PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PRPOPrecipio Inc
      01/10/20234:45PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PRPOPrecipio Inc
      01/03/20235:10PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PRPOPrecipio Inc
      12/20/20224:02PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PRPOPrecipio Inc
      12/06/202210:00AMGlobeNewswire Inc.Precipio Signs Additional Major HemeScreen™ CustomerNASDAQ:PRPOPrecipio Inc
      11/21/20225:12PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PRPOPrecipio Inc
      11/10/20224:05PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PRPOPrecipio Inc
      11/07/202210:30AMGlobeNewswire Inc.Precipio Presents Poster on HemeScreen® Study at Association of Molecular Pathology (AMP) 2022 Annual ConferenceNASDAQ:PRPOPrecipio Inc
      11/04/20226:04AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PRPOPrecipio Inc
       Showing the most relevant articles for your search:NASDAQ:PRPO